Ardelyx (ARDX) Accumulated Expenses (2013 - 2026)
Ardelyx (ARDX) reported Accumulated Expenses of $9.4 million for Q1 2026, down 78.05% on a YoY basis from $42.7 million in Q1 2025, and down 80.28% quarter-over-quarter from $47.6 million in Q4 2025.
Ardelyx (ARDX) Accumulated Expenses (2013 - 2026) Analysis & Trends
Ardelyx has reported Accumulated Expenses for 14 years, with the latest figure at $9.4 million in Q1 2026.
- For the quarter ending Q1 2026, Accumulated Expenses fell 78.05% year-over-year to $9.4 million; the trailing twelve-month figure through Mar 2026 stood at $9.4 million (down 78.05% YoY), and the FY2025 full-year result was $47.6 million, up 37.34% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $9.4 million, down from $47.6 million in the prior quarter.
- The five-year high for Accumulated Expenses was $47.6 million in Q4 2025, with the low at $6.8 million in Q1 2022.
- Historically, Accumulated Expenses has averaged $18.6 million across 5 years, with a median of $11.5 million in 2024.
- Annual changes were most pronounced in 2025 — Accumulated Expenses surged 289.76% — and 2026, when it tumbled 78.05%.
- Ardelyx's Accumulated Expenses stood at $7.5 million in 2022, then soared by 99.27% to $15.0 million in 2023, then soared by 130.32% to $34.6 million in 2024, then jumped by 37.34% to $47.6 million in 2025, then plunged by 80.28% to $9.4 million in 2026.
- The last three Accumulated Expenses figures came in at $9.4 million (Q1 2026), $47.6 million (Q4 2025), and $15.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ardelyx | 1.49 Bn | 1.25 Bn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.38 Mn |
| Dec 31, 2025 | 47.58 Mn |
| Sep 30, 2025 | 15.06 Mn |
| Jun 30, 2025 | 40.76 Mn |
| Mar 31, 2025 | 42.74 Mn |
| Dec 31, 2024 | 34.64 Mn |
| Sep 30, 2024 | 11.54 Mn |
| Jun 30, 2024 | 10.46 Mn |
| Mar 31, 2024 | 21.99 Mn |
| Dec 31, 2023 | 15.04 Mn |
| Sep 30, 2023 | 19.04 Mn |
| Jun 30, 2023 | 6.88 Mn |
| Mar 31, 2023 | 11.05 Mn |
| Dec 31, 2022 | 7.55 Mn |
| Sep 30, 2022 | 7.34 Mn |
| Jun 30, 2022 | 7.94 Mn |
| Mar 31, 2022 | 6.78 Mn |
| Dec 31, 2021 | 5.42 Mn |
| Sep 30, 2021 | 11.37 Mn |
| Jun 30, 2021 | 8.55 Mn |